| Rite Aid Pharmacy 04812 | |
| 981 W Side Ave, Jersey City, New Jersey 07306 | |
| (201) 332-0410 |
| Name | Rite Aid Pharmacy 04812 |
|---|---|
| Organization Name | Rite Aid Of New Jersey Inc |
| Location | 981 W Side Ave, Jersey City, New Jersey 07306 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (201) 332-0410 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Despite the increasing risks of mosquito-transmitted epidemics in the United States and Mexico, policymakers in both countries have made little effort to prevent future outbreaks, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.
In tonight's State of the Union Address President Obama failed to announce any new approach to America's role in the world, instead sticking to vague rhetoric about development, the global HIV/AIDS crisis, and other global health priorities.
A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.
Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration has accepted the filing of the company's New Drug Application for Luveniq™ (oral voclosporin) and has granted the application priority review.
North Carolina Central University's Julius L. Chambers Biomedical/Biotechnology Research Institute is launching a pilot program to examine how research-based health findings can be used more effectively to address health disparities and improve patient care in minority populations.
› Verified 5 days ago
| NPI Number | 1164947982 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID #20689 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 981 W Side Ave, Jersey City, NJ 07306 |
| Phone Number | 201-332-0410 |
News Archive
Despite the increasing risks of mosquito-transmitted epidemics in the United States and Mexico, policymakers in both countries have made little effort to prevent future outbreaks, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.
In tonight's State of the Union Address President Obama failed to announce any new approach to America's role in the world, instead sticking to vague rhetoric about development, the global HIV/AIDS crisis, and other global health priorities.
A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.
Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration has accepted the filing of the company's New Drug Application for Luveniq™ (oral voclosporin) and has granted the application priority review.
North Carolina Central University's Julius L. Chambers Biomedical/Biotechnology Research Institute is launching a pilot program to examine how research-based health findings can be used more effectively to address health disparities and improve patient care in minority populations.
› Verified 5 days ago
| NPI Number | 1902916679 |
| Organization Name | RITE AID OF NEW JERSEY INC |
| Doing Business As | RITE AID PHARMACY 04812 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 981 West Side Avenue, Jersey City, NJ 07306 |
| Phone Number | 201-332-0410 |
News Archive
Despite the increasing risks of mosquito-transmitted epidemics in the United States and Mexico, policymakers in both countries have made little effort to prevent future outbreaks, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.
In tonight's State of the Union Address President Obama failed to announce any new approach to America's role in the world, instead sticking to vague rhetoric about development, the global HIV/AIDS crisis, and other global health priorities.
A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.
Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration has accepted the filing of the company's New Drug Application for Luveniq™ (oral voclosporin) and has granted the application priority review.
North Carolina Central University's Julius L. Chambers Biomedical/Biotechnology Research Institute is launching a pilot program to examine how research-based health findings can be used more effectively to address health disparities and improve patient care in minority populations.
› Verified 5 days ago
News Archive
Despite the increasing risks of mosquito-transmitted epidemics in the United States and Mexico, policymakers in both countries have made little effort to prevent future outbreaks, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.
In tonight's State of the Union Address President Obama failed to announce any new approach to America's role in the world, instead sticking to vague rhetoric about development, the global HIV/AIDS crisis, and other global health priorities.
A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.
Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration has accepted the filing of the company's New Drug Application for Luveniq™ (oral voclosporin) and has granted the application priority review.
North Carolina Central University's Julius L. Chambers Biomedical/Biotechnology Research Institute is launching a pilot program to examine how research-based health findings can be used more effectively to address health disparities and improve patient care in minority populations.
› Verified 5 days ago
Health Aid Drugs Inc Type: Pharmacy Location: 212 Palisade Ave, Jersey City, New Jersey 07306 Phone: (201) 653-1441 | |
Rite Aid Pharmacy 01661 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2859 John F Kennedy Blvd, Jersey City, New Jersey 07306 Phone: (201) 433-2826 | |
Rite Aid Pharmacy 04812 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 981 W Side Ave, Jersey City, New Jersey 07306 Phone: (201) 332-0410 | |
Cvs Pharmacy #17006 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 14th St, Jersey City, New Jersey 07310 Phone: (201) 499-0018 | |
Cvs Pharmacy#11088 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 88 Morgan Street, Jersey City, New Jersey 07302 Phone: (201) 433-3510 |